Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval

BACKGROUND: Mesenchymal stromal cells (MSCs) may reduce mortality in patients with COVID-19; however, early evidence is based on few studies with marked interstudy heterogeneity. The second iteration of our living systematic review and meta-analysis evaluates a framework needed for synthesizing evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkham, Aidan M, Bailey, Adrian J M, Monaghan, Madeline, Shorr, Risa, Lalu, Manoj M, Fergusson, Dean A, Allan, David S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Human Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299509/
https://www.ncbi.nlm.nih.gov/pubmed/35758400
http://dx.doi.org/10.1093/stcltm/szac038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299509/
https://www.ncbi.nlm.nih.gov/pubmed/35758400
http://dx.doi.org/10.1093/stcltm/szac038

Ejemplares similares